2. Academic Validation
  3. Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists

  • J Med Chem. 1994 Jul 22;37(15):2253-7. doi: 10.1021/jm00041a001.
J W Clitherow 1,  D I Scopes,  M Skingle,  C C Jordan,  W Feniuk,  I B Campbell,  M C Carter,  E W Collington,  H E Connor,  G A Higgins, et al.
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Glaxo Research and Development Ltd., Ware, Hertfordshire, England.
PMID: 8057272 DOI: 10.1021/jm00041a001
Figures
Products